Filing Details

Form Type:
4
Zero Holdings:
No
Publication Time:
2009-09-23 12:31:45
Reporting Period:
2009-09-22
Issuer
Cik Name Symbol Sector (SIC) IRS No
1382911 Orexigen Therapeutics Inc. OREX ()
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1280249 Iii K Daniel Turner C/O Orexigen Therapeutics, Inc
3344 N. Torrey Pines Court, Suite 200
La Jolla CA 92037
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2009-09-22 100,000 $10.22 1,298,712 No 4 S Indirect By Montreux Equity Partners II, SBIC, LP, Montreux Equity Partners III, SBIC, LP and related funds
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By Montreux Equity Partners II, SBIC, LP, Montreux Equity Partners III, SBIC, LP and related funds